{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/07/3269056/0/en/Inhibikase-Therapeutics-Announces-Enrollment-of-First-Patient-in-IMPROVE-PAH-Global-Phase-3-Study-of-IKT-001-in-the-Treatment-of-Pulmonary-Arterial-Hypertension.html", "message": "News view counter 650800 successfully enlarged"}